Dynamic Healthcare M&A Database

Acquiring Party	Inverness Medical Innovations, Inc. (AMEX: IMA), a provider of diagnostic products for women’s health and chronic disease self-management.
Transferring Party	BBI Holdings Plc (LSE:AIM), a UK-based manufacturer of non-invasive in vitro diagnostic tests, such as OTC pregnancy tests.
Sector	Diagnostics
Date	December 17, 2007
Analysis BBI's capabilities in developing novel rapid in vitro diagnostic products and high performance reagents and biological materials for use in those products complement Inverness' existing business. Inverness had a preexisting minority stake. Deal value -- $170m. Inverness, which has been on a corporate buying spree, recently acquired ParadigmHealth Inc., a provider of disease management services for $230m., among other companies.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 4Q07